临床显著MRI不可见前列腺癌的临床与读片相关因素
多变量模型显示FN病例更常有阳性家族史、黑人种族、高PSA密度及PI-RADS 2分。FN的mpMRI更常由无专科培训且年读片量较低的放射科医生判读。
要点
- 阴性mpMRI人群中,csPCa的临床预测因素与总体相似。
- FN病例更常见良性前列腺增生和前列腺炎的MRI征象。
- 放射科医生年读片量>50例对FN有保护作用。
核心结论
- 阴性mpMRI患者中csPCa的临床预测因素仍相似,MRI良性前列腺增生和前列腺炎征象及读片量低可区分FN与TP病例。
主要发现
- FN病例相比TN更常有阳性家族史、黑人种族、高PSA密度和更多PI-RADS 2分。
- FN的mpMRI更常由无专科培训的放射科医生判读(P = .001),且年读片量更低(68/y vs 84/y,P < .001)。
- 相比TP,FN病例的csPCa体积和分级更低(Gleason Grade Group:FN 76% vs TP 46)。
- FN病例更常见良性前列腺增生和前列腺炎的MRI征象,且mpMRI读片量更低。
- 放射科医生年读片量>50例在两项分析中均对FN有保护作用。
关键数值与推荐
- csPCa定义为Gleason Grade Group ≥ 2,阳性mpMRI定义为PI-RADS ≥ 3。
- 4069例阴性mpMRI后初始推迟活检的患者中,17%重复mpMRI,12%活检,3.4%在中位2年时发现csPCa。
临床怎么用
- 对于阴性mpMRI患者,应结合家族史、种族、PSA密度及MRI良性前列腺增生/前列腺炎征象综合评估csPCa风险。
- 提高放射科医生mpMRI读片经验(年读片量>50例)可能减少FN。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Multiparametric MRI (mpMRI) is increasingly used to reduce unnecessary prostate biopsies while maintaining detection of clinically significant prostate cancer (csPCa). False-negative (FN) mpMRI leads to delayed diagnosis. This study aimed to identify clinical and reader associated factors associated with FN mpMRI. MATERIALS AND METHODS: We retrospectively identified patients who underwent prostate mpMRI followed by prostate biopsy within 1 year. FN cases were compared with true negative (TN) cases in analysis #1 and to true positive cases in analysis #2 using logistic regression and propensity score matching. A sensitivity analysis assessed patients who initially deferred biopsy after negative mpMRI. csPCa was defined as Gleason Grade Group ≥ 2 and positive mpMRI as Prostate Imaging Reporting and Data System ≥ 3. RESULTS: Six thousand six hundred seventy-nine biopsied patients were identified with 663 TN, 133 FN, and 2993 true positive cases included. Multivariable models predicting csPCa in the negative mpMRI setting found FN cases more frequently had a positive family history, Black race, high PSA density, and more Prostate Imaging Reporting and Data System 2 compared with TN cases. FN mpMRIs were more often read by radiologists without fellowship training (P = .001) and with fewer cumulative annual mpMRI reads (68/y vs 84/y, P < .001). Compared with TP cases, FN cases had lower csPCa volume and grade (Gleason Grade Group: FN 76% vs TP 46). FN cases had more frequent MRI signs of benign prostatic hyperplasia and prostatitis and lower mpMRI radiologist read volume compared with TP cases. Radiologist reads > 50/y was protective against FN mpMRI in both analyses. Of 4069 patients initially deferring biopsy after negative mpMRI, 17% had repeat mpMRI, 12% had biopsy, and 3.4% had csPCa at a median of 2 years. CONCLUSIONS: Clinical predictors of csPCa remain similar among patients with negative mpMRI. MRI benign prostatic hyperplasia and prostatitis along with lower radiologist read volume differentiated FN from TP cases. Enhanced clinical stratification tools and mpMRI refinements could improve confidence in forgoing biopsy for patients with a negative mpMRI.
引用
- Schnauss M, Handa N, Nateghi R, et al. Clinical and Reader Associated Correlates of Clinically Significant Magnetic Resonance Imaging-Invisible Prostate Cancer Based on Negative Scans. J Urol. 2026. PMID: 41871319. doi:10.1097/JU.0000000000005028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。